(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
2 days till quarter result
(amc 2024-05-07)
Expected move: +/- 3.41%
-0.29% $ 34.87
@ $38.14
Emitido: 14 feb 2024 @ 09:30
Retorno: -8.57%
Señal anterior: feb 13 - 09:30
Señal anterior:
Retorno: -0.52 %
Live Chart Being Loaded With Signals
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada...
Stats | |
---|---|
Volumen de hoy | 52 237.00 |
Volumen promedio | 60 977.00 |
Capitalización de mercado | 831.80M |
EPS | $0 ( 2024-04-30 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-07 |
Last Dividend | $0.120 ( 2023-12-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 27.90 |
ATR14 | $0.0450 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-31 | Stacy Linda | Buy | 0 | |
2024-03-27 | Nunnelly John N | Buy | 9 259 | Common Stock |
2024-03-27 | Nunnelly John N | Sell | 3 487 | Common Stock |
2024-03-27 | Nunnelly John N | Sell | 9 259 | Director Stock Option (Right to Buy) |
2024-03-01 | Common Property Trust | Sell | 598 653 | Common Stock |
INSIDER POWER |
---|
-90.80 |
Last 96 transactions |
Buy: 143 501 | Sell: 1 953 935 |
Volumen Correlación
National Research Corp Correlación
10 Correlaciones Más Positivas | |
---|---|
ARIZ | 0.884 |
BIOC | 0.878 |
EZGO | 0.873 |
ATRC | 0.86 |
POAI | 0.858 |
ATHN | 0.858 |
AFYA | 0.856 |
AEY | 0.85 |
ARVL | 0.849 |
FIVE | 0.845 |
10 Correlaciones Más Negativas | |
---|---|
MOTNU | -0.899 |
SOHU | -0.89 |
SGRP | -0.889 |
CENX | -0.887 |
SMTC | -0.887 |
LABP | -0.877 |
TGLS | -0.875 |
NN | -0.872 |
SCTL | -0.869 |
VFF | -0.869 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
National Research Corp Correlación - Moneda/Commodity
National Research Corp Finanzas
Annual | 2023 |
Ingresos: | $148.58M |
Beneficio Bruto: | $86.67M (58.33 %) |
EPS: | $1.260 |
FY | 2023 |
Ingresos: | $148.58M |
Beneficio Bruto: | $86.67M (58.33 %) |
EPS: | $1.260 |
FY | 2022 |
Ingresos: | $151.57M |
Beneficio Bruto: | $94.52M (62.36 %) |
EPS: | $1.280 |
FY | 2021 |
Ingresos: | $147.95M |
Beneficio Bruto: | $95.60M (64.62 %) |
EPS: | $1.473 |
Financial Reports:
No articles found.
National Research Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.240 (N/A) |
$0.120 (N/A) |
$0.120 (N/A) |
$0.120 (N/A) |
$1.120 (N/A) |
$0.120 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0600 | 2014-12-29 |
Last Dividend | $0.120 | 2023-12-28 |
Next Dividend | $0 | N/A |
Payout Date | 2024-01-12 | |
Next Payout Date | N/A | |
# dividends | 35 | -- |
Total Paid Out | $6.34 | -- |
Avg. Dividend % Per Year | 1.58% | -- |
Score | 4.63 | -- |
Div. Sustainability Score | 8.98 | |
Div.Growth Potential Score | 5.34 | |
Div. Directional Score | 7.16 | -- |
Year | Amount | Yield |
---|---|---|
2014 | $0.0600 | 0.32% |
2015 | $0.620 | 4.48% |
2016 | $0.340 | 2.23% |
2017 | $0.400 | 2.13% |
2018 | $1.130 | 3.07% |
2019 | $0.780 | 2.04% |
2020 | $0.210 | 0.32% |
2021 | $0.480 | 1.12% |
2022 | $0.840 | 1.99% |
2023 | $1.480 | 3.80% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.208 | 1.500 | 5.83 | 8.75 | [0 - 0.5] |
returnOnAssetsTTM | 0.253 | 1.200 | 1.568 | 1.882 | [0 - 0.3] |
returnOnEquityTTM | 0.478 | 1.500 | 5.80 | 8.70 | [0.1 - 1] |
payoutRatioTTM | 1.174 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 0.673 | 0.800 | -1.636 | -1.309 | [1 - 3] |
quickRatioTTM | 0.532 | 0.800 | -1.574 | -1.259 | [0.8 - 2.5] |
cashRatioTTM | 0.184 | 1.500 | -0.0902 | -0.135 | [0.2 - 2] |
debtRatioTTM | 0.305 | -1.500 | 4.92 | -7.39 | [0 - 0.6] |
interestCoverageTTM | 46.46 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.560 | 2.00 | 9.48 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.914 | 2.00 | 9.54 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.762 | -1.500 | 6.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.613 | 1.000 | 3.11 | 3.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.270 | 1.000 | 6.61 | 6.61 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.022 | 1.000 | 5.43 | 5.43 | [0.2 - 2] |
assetTurnoverTTM | 1.214 | 0.800 | 5.24 | 4.19 | [0.5 - 2] |
Total Score | 8.98 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 27.51 | 1.000 | 7.32 | 0 | [1 - 100] |
returnOnEquityTTM | 0.478 | 2.50 | 7.30 | 8.70 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.914 | 2.00 | 9.70 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.24 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.560 | 2.00 | 9.48 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.174 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -6.05 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.257 | 1.000 | 6.09 | 0 | [0.1 - 0.5] |
Total Score | 5.34 |
National Research Corp
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico